Optimization of Retroviral Gene Transfer Protocol to Maintain the Lymphoid Potential of Progenitor Cells-Reference-Cited by-同舟云学术

Optimization of Retroviral Gene Transfer Protocol to Maintain the Lymphoid Potential of Progenitor Cells

Published:2001-02-10 Issue:3 Volume:12 Page:291-301
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Hacein-Bey Salima¹,Gross Fabian²,Nusbaum Patrick²,Hue Christophe²,Hamel Yamina³,Fischer Alain⁴,Cavazzana-Calvo Marina¹

Affiliation:

1. Unité Inserm U429; Laboratoire de Thérapie Génique and Laboratoire de Thérapie Cellulaire, Hôpital Necker, 75743 Paris Cedex 15, France.

2. Laboratoire de Thérapie Génique, Hôpital Necker, 75743 Paris Cedex 15, France.

3. Unité Inserm U429, Hôpital Necker, 75743 Paris Cedex 15, France.

4. Unité Inserm U429; Laboratoire de Thérapie Génique and Unité d'Immunologie et d'Hématologie Pédiatriques, Hôpital Necker, 75743 Paris Cedex 15, France.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/10430340150218422

Reference66 articles.

1. Murine Stromal Cells Counteract the Loss of Long-Term Culture-Initiating Cell Potential Induced by Cytokines in CD34+CD38low/neg Human Bone Marrow Cells

2. Individual CD34+CD38lowCD19−CD10− Progenitor Cells From Human Cord Blood Generate B Lymphocytes and Granulocytes

3. Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells.

4. Stroma-conditioned medium and sufficient prestimulation improve fibronectin fragment-mediated retroviral gene transfer into human primitive mobilized peripheral blood stem cells through effects on their recovery and transduction efficiency

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?;Human Gene Therapy;2016-02

2. Gene Therapy Researchers' Assessments Of Risks And Perceptions Of Risk Acceptability In Clinical Trials;Molecular Therapy;2013-04

3. The evolution of gene therapy in X-linked severe combined immunodeficiency;Annals of Allergy, Asthma & Immunology;2009-05

4. Identification of Host Proteins Associated with Retroviral Vector Particles by Proteomic Analysis of Highly Purified Vector Preparations;Journal of Virology;2008-02

5. Genotoxicity of Retroviral Integration In Hematopoietic Cells;Molecular Therapy;2006-06